Cargando…

Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine

OBJECTIVE: Precision medicine requires reliable identification of variation in patient-level outcomes with different available treatments, often termed treatment effect heterogeneity. We aimed to evaluate the comparative utility of individualized treatment selection strategies based on predicted ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venkatasubramaniam, Ashwini, Mateen, Bilal A., Shields, Beverley M., Hattersley, Andrew T., Jones, Angus G., Vollmer, Sebastian J., Dennis, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276367/ https://www.ncbi.nlm.nih.gov/pubmed/37328784 http://dx.doi.org/10.1186/s12911-023-02207-2

Ejemplares similares

Identifying Good Responders to Glucose Lowering Therapy in Type 2 Diabetes: Implications for Stratified Medicine
por: Jones, Angus G., et al.
Publicado: (2014)

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
por: Dennis, John M, et al.
Publicado: (2019)

Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity
por: Bowman, P., et al.
Publicado: (2018)

The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation
por: McGovern, Andrew P., et al.
Publicado: (2021)

Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach
por: Dennis, John M, et al.
Publicado: (2018)

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
por: McGovern, Andrew P., et al.
Publicado: (2019)

Causal machine learning for healthcare and precision medicine
por: Sanchez, Pedro, et al.
Publicado: (2022)

Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020*
por: Dennis, John M., et al.
Publicado: (2020)

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017
por: Curtis, Helen J., et al.
Publicado: (2018)

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
por: Jones, Angus G., et al.
Publicado: (2016)

Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults
por: Lynam, Anita L., et al.
Publicado: (2020)

Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020
por: Dennis, John M., et al.
Publicado: (2021)

The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2022)

Correction to: The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2023)

A national retrospective study of the association between serious operational problems and COVID-19 specific intensive care mortality risk
por: Wilde, Harrison, et al.
Publicado: (2021)

High Resolution Treatment Effects Estimation: Uncovering Effect Heterogeneities with the Modified Causal Forest
por: Bodory, Hugo, et al.
Publicado: (2022)

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019)

Identifying routine clinical predictors of non‐adherence to second‐line therapies in type 2 diabetes: A retrospective cohort analysis in a large primary care database
por: Shields, Beverley M., et al.
Publicado: (2019)

Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
por: McGovern, Andrew P, et al.
Publicado: (2020)

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
por: Jones, Angus G, et al.
Publicado: (2012)

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study
por: Rodgers, Lauren R., et al.
Publicado: (2021)

Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in the United Kingdom: A National Cohort Study, March 2020 to January 2021*
por: Dennis, John M., et al.
Publicado: (2021)

Financial Development and Unemployment in MENA: Evidence from Heterogeneous Panel Causality and Quantile via Moment Regression
por: Raifu, Isiaka Akande, et al.
Publicado: (2023)

Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studies
por: Greiner, Rosamund, et al.
Publicado: (2021)

Metabolomics reveals intratumor heterogeneity – Implications for precision medicine
por: Liu, Xiaojing, et al.
Publicado: (2017)

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
por: Kanzaki, Ryu, et al.
Publicado: (2020)

Precision Medicine and Heterogeneity of Treatment Effect in Therapies for ARDS
por: Khan, Yasin A., et al.
Publicado: (2021)

Covariance regression with random forests
por: Alakus, Cansu, et al.
Publicado: (2023)

Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters
por: Knight, Bridget A, et al.
Publicado: (2016)

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017
por: Dennis, John M., et al.
Publicado: (2019)

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
por: Shields, Beverley M, et al.
Publicado: (2015)

Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
por: Shields, Beverley M, et al.
Publicado: (2023)

Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors
por: Young, Katherine G, et al.
Publicado: (2023)

From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
por: den Hollander, Nicoline H. M., et al.
Publicado: (2022)

Patient stratification for determining optimal second and third line therapy for type 2 diabetes: the TriMaster study
por: Shields, Beverley M, et al.
Publicado: (2023)

Regression Discontinuity for Causal Effect Estimation in Epidemiology
por: Oldenburg, Catherine E., et al.
Publicado: (2016)

Heterogeneous genetic architecture by gender for precision medicine of cardiovascular disease
por: Lee, Chaeyoung
Publicado: (2018)

Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
por: Röcken, Christoph, et al.
Publicado: (2021)

Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
por: Rosati, Gerardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9p0hnkjpplvl2dvghpgddk5ran